AREXIS AB innovation strategy

Patent filings in countries

#	Country	Total Patents
#1	United States	14
#2	EPO (European Patent Office)	10
#3	WIPO (World Intellectual Property Organization)	10
#4	Australia	9
#5	Canada	9
#6	China	2
#7	Hong Kong	2
#8	Israel	2
#9	Republic of Korea	2
#10	Norway	2
#11	New Zealand	2
#12	Slovakia	2
#13	Finland	1
#14	Japan	1

#	Technology
#1	Microorganisms
#2	Medical preparations
#3	Therapeutic chemical compounds
#4	Animal care
#5	Analysing materials
#6	Enzymes
#7	Peptides
#8	Measuring microorganism processes
#9	Dairy products
#10	Foods

Publication	Filing date	Title
WO2005095986A2	2005-04-01	New method
CN101152185A	2004-06-07	Use of heterocyclic compounds as SCCE inhibitors
CN1802160A	2004-06-07	Use of heterocyclic compounds as SCCE inhibitors
US7294652B2	2003-05-13	Autoimmune conditions and NADPH oxidase defects
EP1476464A1	2003-01-31	Variants of the alpha 1 subunit of human ampk
EP1474520A2	2003-01-31	Prkag3 gene promoter and uses thereof
AU2003209552B2	2003-01-31	Transgenic animals expressing prkag3
NZ533848A	2003-01-09	Detection of mutations in the flavin-containing monooxygenase (FMO3) gene
US7148020B2	2002-07-11	Triple polypeptide complexes
AU2002304326A1	2002-02-28	Genetic research system
CA2423983A1	2001-10-01	An immunogenic iscom complex comprising an enzymatically active a1 subunit of the cholera toxin or e. coli heat labile enterotoxin fused to a dimer of the d region of protein a
AU4700801A	2001-04-06	Variants of the human amp-activated protein kinase gamma 3 subunit
US6465714B2	1999-11-05	Congenic animal models of non-insulin dependent diabetes mellitus